Health Research & Education

Healthcare Megatrends to watch in 2018

Megatrends are fundamentally changing the way the world works. The three forces driving massive global healthcare trends include: unparalleled advances in technology; the sedentary lifestyles that goes hand in hand with economic development, globalisation and urbanisation; and the demographics of our aging population. The world is aging, and as a result there has been massive…

Read More

How is Australia responding to the medicinal cannabis industry?

Following the legalisation of cannabis for medicinal use by the Federal Government in 2016, there has been plenty of discussion about whether the products, including oils, sprays, patches and tablets, will sink or swim both in Australia’s community and our economy.   There’s not a day that goes by without the media talking about a…

Read More

New report cites 23 child deaths could have been prevented through appropriate vaccination

On Thursday, January 11, 2018, a major report entitled, ‘Child Deaths from Vaccine Preventable Infectious Diseases‘ between 2005 and 2014 was published in the Journal of Paediatrics and Child Health. Report authors – National Centre for Immunisation Research and Surveillance (NCIRS), the Sydney Children’s Hospital Network and University of Sydney researchers – cited 54 child…

Read More

National Education Initiative launched to support youth mental health

Leading Australian mental health organisations have come together today to announce the launch of a new National Education Initiative transforming the country’s approach to youth care. From August 2018, beyondblue, headspace, and Early Childhood Australia will attempt to provide an end-to-end mental health framework in schools. The National Education Initiative has attracted AUD$45m in funding…

Read More

Australian developed, first-in-class rheumatoid arthritis medication secures green-light for human trials in Brisbane

Australia’s first in-human study of a first-in-class rheumatoid arthritis immunotherapy treatment developed by University of Queensland researchers was launched on November 14, 2017. The Phase 1, double-blind, placebo-controlled study currently underway at Brisbane’s Princess Alexandra Hospital, will consider both single-ascending dose, and multi-dose protocols to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous (under…

Read More